Podcast
Questions and Answers
What is the primary rationale behind the increasing interest in targeting epigenetic alterations for cancer treatment?
What is the primary rationale behind the increasing interest in targeting epigenetic alterations for cancer treatment?
Which of the following best describes the current status of drugs targeting histone acetylation and DNA methylation?
Which of the following best describes the current status of drugs targeting histone acetylation and DNA methylation?
For which specific types of cancer have decitabine and azacytidine been approved for clinical use by the FDA and EMA?
For which specific types of cancer have decitabine and azacytidine been approved for clinical use by the FDA and EMA?
What is the primary mechanism of action of decitabine and azacytidine in treating cancer?
What is the primary mechanism of action of decitabine and azacytidine in treating cancer?
Signup and view all the answers
What is the significance of targeting epigenetic pathways in cancer therapy compared to traditional chemotherapy?
What is the significance of targeting epigenetic pathways in cancer therapy compared to traditional chemotherapy?
Signup and view all the answers
Flashcards
Epigenetic therapy
Epigenetic therapy
A treatment approach targeting reversible epigenetic changes in cancer.
Histone acetylation
Histone acetylation
The process of adding acetyl groups to histones, impacting gene expression.
DNA methylation
DNA methylation
The addition of methyl groups to DNA, often silencing genes.
Decitabine
Decitabine
Signup and view all the flashcards
Clinical trials
Clinical trials
Signup and view all the flashcards
Study Notes
Epigenetic Therapy in Cancer
- Epigenetic alterations in cancer are reversible, making them a potential target for therapy.
- Drugs targeting histone acetylation and DNA methylation are being developed.
- Clinical trials of these drugs show promising results for epigenetic therapy.
- Decitabine (Dacogen®) and azacytidine (Vidaza®, Azadine®, Onureg®) are approved DNA demethylating agents.
- These drugs are used for haematological malignancies and myelodysplastic syndromes (MDS).
- FDA and EMA have approved their clinical use.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Explore the revolutionary field of epigenetic therapy in cancer treatment. This quiz delves into the mechanisms of epigenetic alterations, the development of drugs targeting histone acetylation and DNA methylation, and the promising results from clinical trials. Understand the applications of approved agents like Decitabine and Azacytidine in treating hematological malignancies.